Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2024

Genmab — Februar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #1470

    I er fulde af vittige replikker i dag - kommer i alle fra samme skole: https://www.pinterest.com/pin/midvale-school-for-the-gifted--416723771780044122/

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #1471

      Jeg antog vi kigge på regnskab og det var et nøgletal du havde brygget sammen på det. Men det er så mere fluffy end det 😉

      1 Reply Last reply
      0
      • JørgenVarnæsJ Offline
        JørgenVarnæsJ Offline
        JørgenVarnæs
        wrote on sidst redigeret af
        #1472

        aaah - det er roi siden ipo på aktien. Det burde jeg nok have specificeret

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #1473

          Det må også siges at være til den fluffy side. Men dog et afkast mange ville være tilfredse med.

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #1474

            The best is yet to come https://www.fiercebiotech.com/biotech/jj-shut-down-massive-bay-area-rd-facility-less-18-months-after-opening-it

            1 Reply Last reply
            0
            • JørgenVarnæsJ Offline
              JørgenVarnæsJ Offline
              JørgenVarnæs
              wrote on sidst redigeret af
              #1475

              har du kigget på sidste sætning? Lyder det ikke som et selskab vi kender?

              1 Reply Last reply
              0
              • JørgenVarnæsJ Offline
                JørgenVarnæsJ Offline
                JørgenVarnæs
                wrote on sidst redigeret af
                #1476

                men absolut interessant

                1 Reply Last reply
                0
                • JørgenVarnæsJ Offline
                  JørgenVarnæsJ Offline
                  JørgenVarnæs
                  wrote on sidst redigeret af
                  #1477

                  sorry - der var mere efter reklamen - men det var denne sætning "The focus of the campus was emerging gene and RNA-based therapies, plus research on retinal and infectious diseases. "

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #1478

                    Jo døden skal have en årsag. Uanset årsag er det påfaldende at lukke noget ned så hurtigt.

                    1 Reply Last reply
                    0
                    • JørgenVarnæsJ Offline
                      JørgenVarnæsJ Offline
                      JørgenVarnæs
                      wrote on sidst redigeret af
                      #1479

                      mon de tænker, at covid og den slags er bag os, så det skal der ikke investeres i? Tidligere var der også en slet skjult foragt for RNA terapier i videnskabelige kredse

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #1480

                        https://www.jnj.com/media-center/press-releases/johnson-johnson-opens-state-of-the-art-science-and-technology-campus-in-san-francisco-bay-area “ The R&D focus at the new site spans Janssen’s therapeutic areas and key functions”

                        1 Reply Last reply
                        0
                        • JørgenVarnæsJ Offline
                          JørgenVarnæsJ Offline
                          JørgenVarnæs
                          wrote on sidst redigeret af
                          #1481

                          generelt fornemmer jeg dog ikke den store excitement for antistoffer. Det lader til at GLP1 molekulerne har taget hele showet i aktiekredse

                          1 Reply Last reply
                          0
                          • JørgenVarnæsJ Offline
                            JørgenVarnæsJ Offline
                            JørgenVarnæs
                            wrote on sidst redigeret af
                            #1482

                            i onkologi er det noget så usexet som ADC'erne, der har fået comeback

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #1483

                              Ja underligt nok. Moden svinger.

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #1484

                                10 stocks with huge cash position vs capitalisation https://twitter.com/aifininsights/status/1762538260805329352

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1485

                                  Zai Lab will focus on the following strategic priorities in 2024 to drive innovation in China and beyond:
                                  Planned China submissions: [ ]
                                  Tisotumab vedotin in second-line+ cervical cancer

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #1486

                                    Zai Lab to submit an NDA to the NMPA in second-line+ cervical cancer. https://www.businesswire.com/news/home/20240227802106/en/Zai-Lab-Announces-Full-Year-2023-Financial-Results-and-Recent-Corporate-Updates

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #1487

                                      Capital Increase in Genmab as a Result of Employee Warrant Exercise https://www.proinvestor.com/investornyt/1124046/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #1488

                                        Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons https://www.proinvestor.com/investornyt/1124047/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons

                                        1 Reply Last reply
                                        0
                                        • V Offline
                                          V Offline
                                          Vougeot
                                          wrote on sidst redigeret af
                                          #1489

                                          Vi skal på et tidspunkt ned i 1892, så gap'et kan bliver lukket, øv 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper